Medical Molecular Morphology

, Volume 48, Issue 2, pp 76–84 | Cite as

Menstrual cyclic change of metastin/GPR54 in endometrium

  • Tsukasa Baba
  • Hyun Sook Kang
  • Yuko Hosoe
  • Budiman Kharma
  • Kaoru Abiko
  • Noriomi Matsumura
  • Junzo Hamanishi
  • Ken Yamaguchi
  • Yumiko Yoshioka
  • Masafumi Koshiyama
  • Masaki Mandai
  • Susan K. Murphy
  • Ikuo Konishi
Original Paper

Abstract

Metastin/kisspeptin is encoded by KISS1 and functions as an endogenous ligand of GPR54. Interaction of metastin with GPR54 suppresses metastasis and also regulates release of gonadotropin-releasing hormone, which promotes secretion of estradiol (E2) and progesterone (P4). We have previously demonstrated epigenetic regulation of GPR54 in endometrial cancer and the potent role of metastin peptides in inhibiting metastasis in endometrial cancer. However, little is known about how the metastin–GPR54 axis is regulated in the endometrium, the precursor tissue of endometrial cancer. Endometrial stromal cells (ESCs) and endometrial glandular cells (EGCs) within the endometrium show morphological changes when exposed to E2 and P4. In this study, we show that metastin expression is induced in ESCs through decidualization, but is repressed in glandular components of atypical endometrial hyperplasia (AEH) and endometrial cancer relative to EGCs. The promoter of GPR54 is unmethylated in normal endometrium and in AEH. These results indicate metastin may function in decidualized endometrium to prepare for adequate placentation but this autocrine secretion of metastin is deregulated during oncogenesis to enable tumor cells to spread.

Keywords

Metastin GPR54 Decidualization Endometrium Endometrial cancer 

Supplementary material

795_2014_81_MOESM1_ESM.docx (676 kb)
Supplementary material 1 (DOCX 676 kb)

References

  1. 1.
    Kang HS, Baba T, Mandai M, Matsumura N, Hamanishi J, Kharma B et al (2011) GPR54 is a target for suppression of metastasis in endometrial cancer. Mol Cancer Ther 10:580–590PubMedCrossRefGoogle Scholar
  2. 2.
    Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K et al (2001) Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411:613–617PubMedCrossRefGoogle Scholar
  3. 3.
    Cejudo Roman A, Pinto FM, Dorta I, Almeida TA, Hernandez M, Illanes M et al (2012) Analysis of the expression of neurokinin B, kisspeptin, and their cognate receptors NK3R and KISS1R in the human female genital tract. Fertil Steril 97:1213–1219PubMedCrossRefGoogle Scholar
  4. 4.
    Makri A, Msaouel P, Petraki C, Milingos D, Protopapas A, Liapi A et al (2012) KISS1/KISS1R expression in eutopic and ectopic endometrium of women suffering from endometriosis. In Vivo 26:119–127PubMedGoogle Scholar
  5. 5.
    Noyes RW, Hertig AT, Rock J (1975) Dating the endometrial biopsy. Am J Obstet Gynecol 122:262–263PubMedGoogle Scholar
  6. 6.
    Kosaka K, Fujiwara H, Tatsumi K, Yoshioka S, Higuchi T, Sato Y et al (2003) Human peripheral blood mononuclear cells enhance cell–cell interaction between human endometrial epithelial cells and BeWo-cell spheroids. Hum Reprod 18:19–25PubMedCrossRefGoogle Scholar
  7. 7.
    Inoue T, Kanzaki H, Imai K, Narukawa S, Higuchi T, Katsuragawa H et al (1994) Bestatin, a potent aminopeptidase-N inhibitor, inhibits in vitro decidualization of human endometrial stromal cells. J Clin Endocrinol Metab 79:171–175PubMedGoogle Scholar
  8. 8.
    Marshburn PB, Head JR, MacDonald PC, Casey ML (1992) Culture characteristics of human endometrial glandular epithelium throughout the menstrual cycle: modulation of deoxyribonucleic acid synthesis by 17 beta-estradiol and medroxyprogesterone acetate. Am J Obstet Gynecol 167:1888–1898PubMedCrossRefGoogle Scholar
  9. 9.
    Sugino N, Kashida S, Takiguchi S, Nakamura Y, Kato H (2000) Induction of superoxide dismutase by decidualization in human endometrial stromal cells. Mol Hum Reprod 6:178–184PubMedCrossRefGoogle Scholar
  10. 10.
    Sugino N, Karube-Harada A, Sakata A, Takiguchi S, Kato H (2002) Different mechanisms for the induction of copper-zinc superoxide dismutase and manganese superoxide dismutase by progesterone in human endometrial stromal cells. Hum Reprod 17:1709–1714PubMedCrossRefGoogle Scholar
  11. 11.
    Matsuoka A, Kizuka F, Lee L, Tamura I, Taniguchi K, Asada H et al (2010) Progesterone increases manganese superoxide dismutase expression via a cAMP-dependent signaling mediated by noncanonical Wnt5a pathway in human endometrial stromal cells. J Clin Endocrinol Metab 95:E291–E299PubMedCrossRefGoogle Scholar
  12. 12.
    Liu M, Matsumura N, Mandai M, Li K, Yagi H, Baba T et al (2009) Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression. Mod Pathol 22:373–384PubMedCrossRefGoogle Scholar
  13. 13.
    Estella C, Herrer I, Moreno-Moya JM, Quinonero A, Martinez S, Pellicer A et al (2012) miRNA signature and Dicer requirement during human endometrial stromal decidualization in vitro. PLoS One 7:e41080PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK et al (2003) The GPR54 gene as a regulator of puberty. N Engl J Med 349:1614–1627PubMedCrossRefGoogle Scholar
  15. 15.
    de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E (2003) Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 100:10972–10976PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Messager S, Chatzidaki EE, Ma D, Hendrick AG, Zahn D, Dixon J et al (2005) Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc Natl Acad Sci USA 102:1761–1766PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Smith JT, Dungan HM, Stoll EA, Gottsch ML, Braun RE, Eacker SM et al (2005) Differential regulation of KiSS-1 mRNA expression by sex steroids in the brain of the male mouse. Endocrinology 146:2976–2984PubMedCrossRefGoogle Scholar
  18. 18.
    Smith JT, Cunningham MJ, Rissman EF, Clifton DK, Steiner RA (2005) Regulation of Kiss1 gene expression in the brain of the female mouse. Endocrinology 146:3686–3692PubMedCrossRefGoogle Scholar
  19. 19.
    Kinoshita M, Tsukamura H, Adachi S, Matsui H, Uenoyama Y, Iwata K et al (2005) Involvement of central metastin in the regulation of preovulatory luteinizing hormone surge and estrous cyclicity in female rats. Endocrinology 146:4431–4436PubMedCrossRefGoogle Scholar
  20. 20.
    Lups S (1952) In memoriam Gerrit Van Veen. Ned Tijdschr Geneeskd 96:40PubMedGoogle Scholar
  21. 21.
    Adachi S, Yamada S, Takatsu Y, Matsui H, Kinoshita M, Takase K et al (2007) Involvement of anteroventral periventricular metastin/kisspeptin neurons in estrogen positive feedback action on luteinizing hormone release in female rats. J Reprod Dev 53:367–378PubMedCrossRefGoogle Scholar
  22. 22.
    Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, Usuki S et al (2003) Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab 88:914–919PubMedCrossRefGoogle Scholar
  23. 23.
    Pita J, Barrios V, Gavela-Perez T, Martos-Moreno GA, Munoz-Calvo MT, Pozo J et al (2011) Circulating kisspeptin levels exhibit sexual dimorphism in adults, are increased in obese prepubertal girls and do not suffer modifications in girls with idiopathic central precocious puberty. Peptides 32:1781–1786PubMedCrossRefGoogle Scholar
  24. 24.
    Jayasena CN, Nijher GM, Comninos AN, Abbara A, Januszewki A, Vaal ML et al (2011) The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans. J Clin Endocrinol Metab 96:E1963–E1972PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Sato Y, Fujiwara H, Konishi I (2010) Role of platelets in placentation. Med Mol Morphol 43:129–133PubMedCrossRefGoogle Scholar
  26. 26.
    Park DW, Lee SK, Hong SR, Han AR, Kwak-Kim J, Yang KM (2012) Expression of Kisspeptin and its receptor GPR54 in the first trimester trophoblast of women with recurrent pregnancy loss. Am J Reprod Immunol 67:132–139PubMedCrossRefGoogle Scholar
  27. 27.
    Logie JJ, Denison FC, Riley SC, Ramaesh T, Forbes S, Norman JE et al (2012) Evaluation of kisspeptin levels in obese pregnancy as a biomarker for pre-eclampsia. Clin Endocrinol (Oxf) 76:887–893CrossRefGoogle Scholar
  28. 28.
    Bilban M, Ghaffari-Tabrizi N, Hintermann E, Bauer S, Molzer S, Zoratti C et al (2004) Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci 117:1319–1328PubMedCrossRefGoogle Scholar
  29. 29.
    Gunderson CC, Fader AN, Carson KA, Bristow RE (2012) Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol 125:477–482PubMedCrossRefGoogle Scholar
  30. 30.
    Ushijima K, Yahata H, Yoshikawa H, Konishi I, Yasugi T, Saito T et al (2007) Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 25:2798–2803PubMedCrossRefGoogle Scholar
  31. 31.
    Scott G, Ahmad I, Howard K, MacLean D, Oliva C, Warrington S et al (2013) Double-blind, randomized, placebo-controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of TAK-683, an investigational metastin analogue in healthy men. Br J Clin Pharmacol 75:381–391PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Jayasena CN, Nijher GM, Abbara A, Murphy KG, Lim A, Patel D et al (2010) Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrhea. Clin Pharmacol Ther 88:840–847PubMedCrossRefGoogle Scholar
  33. 33.
    Jayasena CN, Nijher GM, Chaudhri OB, Murphy KG, Ranger A, Lim A et al (2009) Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocrinol Metab 94:4315–4323PubMedCrossRefGoogle Scholar
  34. 34.
    Fujiwara H, Jobo T, Takei Y, Saga Y, Imai M, Arai T et al (2012) Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma. Oncol Lett 3:1002–1006PubMedCentralPubMedGoogle Scholar

Copyright information

© The Japanese Society for Clinical Molecular Morphology 2014

Authors and Affiliations

  • Tsukasa Baba
    • 1
  • Hyun Sook Kang
    • 1
  • Yuko Hosoe
    • 1
  • Budiman Kharma
    • 1
  • Kaoru Abiko
    • 1
  • Noriomi Matsumura
    • 1
  • Junzo Hamanishi
    • 1
  • Ken Yamaguchi
    • 1
  • Yumiko Yoshioka
    • 1
  • Masafumi Koshiyama
    • 1
  • Masaki Mandai
    • 2
  • Susan K. Murphy
    • 3
  • Ikuo Konishi
    • 1
  1. 1.Department of Gynecology and ObstetricsKyoto University Graduate School of MedicineKyotoJapan
  2. 2.Department of Obstetrics and Gynecology, Faculty of MedicineKinki UniversityOsakaJapan
  3. 3.Division of Gynecologic Oncology, Department of Obstetrics and GynecologyDuke University Medical CenterDurhamUSA

Personalised recommendations